US2023417778A1PendingUtilityA1

Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer

Assignee: PROMEGA CORPPriority: Dec 12, 2012Filed: Aug 29, 2023Published: Dec 28, 2023
Est. expiryDec 12, 2032(~6.4 yrs left)· nominal 20-yr term from priority
G01N 33/94G01N 33/542G01N 33/582C12Q 1/66
81
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are compositions and methods for detection and analysis of intracellular binding of a bioactive agent to a cellular target. In particular, bioactive agents tethered to fluorophores, cellular targets fused to bioluminescent reporters, and methods of detecting and analyzing the interaction of bioactive agents with cellular targets therewith.

Claims

exact text as granted — not AI-modified
1 . A system comprising:
 (a) a bioactive agent conjugated to a fluorophore;   (b) a polynucleotide for expression of a protein fusion in a cell, said polynucleotide comprising: (i) a protein of interest and (ii) a luciferase, wherein the bioactive agent is capable of binding non-covalently to the protein of interest upon interaction therewith, wherein the emission spectrum of the luciferase overlaps with the excitation spectrum of the fluorophore; and   (c) a substrate for the luciferase.   
     
     
         2 . The system of  claim 1 , wherein the bioactive agent is a small molecule, a peptide or a nucleic acid. 
     
     
         3 . The system of  claim 3 , wherein the nucleic acid is RNA. 
     
     
         4 . The system of  claim 3 , wherein the nucleic acid is DNA. 
     
     
         5 . The system of  claim 1 , wherein the fluorophore is a small molecule fluorophore. 
     
     
         6 . The system of  claim 5 , wherein the small molecule fluorophore is a carboxy rhodamine analog. 
     
     
         7 . The system of  claim 1 , wherein the luciferase comprises a polypeptide with at least 70% sequence identity with SEQ ID NO.: 1. 
     
     
         8 . The system of  claim 1 , wherein the substrate for the luciferase is coelenterazine or a coelenterazine derivative. 
     
     
         9 . The system of  claim 8 , wherein the substrate is 2-furanylmethyl-deoxy-coelenterazine. 
     
     
         10 . The system of  claim 1 , wherein the conjugate of the bioactive agent and fluorophore is added extracellularly and enters the cell 
     
     
         11 . The system of  claim 1 , wherein the bioactive agent conjugated to the fluorophore is cell permeable. 
     
     
         12 . The system of  claim 11 , further comprising a permeabilization agent to potentiate entry of the bioactive agent conjugated to the fluorophore into the cell. 
     
     
         13 . The system of  claim 1 , wherein the protein fusion is one of a plurality of different proteins of interest fused to luciferase. 
     
     
         14 . The system of  claim 1 , wherein the bioactive agent is produced by non-natural chemical synthesis. 
     
     
         15 . The system of  claim 1 , wherein:
 (i) said luciferase has a first emission spectrum with a first peak emission;   (ii) said fluorophore has an excitation spectrum that overlaps said first emission spectrum; and   (iii) said fluorophore has a second emission spectrum with a second peak emission, said second peak emission being separated from said first peak emission.   
     
     
         16 . The system of  claim 15 , wherein said second peak emission is separated from said first peak emission by at least 80 nm. 
     
     
         17 . The system of  claim 1 , wherein upon binding of the bioactive agent to the protein of interest, conversion of the substrate to a reaction product by the luciferase results in excitation of the fluorophore by bioluminescence resonance energy transfer (BRET and fluorescence emission from the fluorophore. 
     
     
         18 . The system of  claim 1 , wherein the polynucleotide is expressed from a vector. 
     
     
         19 . The system of  claim 18 , wherein the vector is a plasmid or viral vector.

Join the waitlist — get patent alerts

Track US2023417778A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.